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The US Institute of Medicine (IOM) defines clini-
cal practice guidelines as “statements that include rec-
ommendations intended to optimize patient care that 
are informed by a systematic review of evidence and 
an assessment of the benefits and harms of alternative 
care options” [1]. Health care guidelines and their ap-
propriate implementation are of interest to health care 
providers, national health organizations, professional 
societies, policy-makers, patients and the public.
The need for quality standards in the development 
of health care guidelines is universally recognized and 
several tools are available to achieve them [2] as well as 
to evaluate their quality and credibility [3].
AGREE II [4], an update of the Appraisal of Guide-
lines for Research & Evaluation instrument [5], is wide-
ly accepted as the international gold standard for the 
appraisal of guidelines. The instrument is composed of 
23 items within 6 quality domains: 1) scope and pur-
pose, 2) stakeholder involvement, 3) rigor of develop-
ment, 4) clarity of presentation, 5) applicability, and 6) 
editorial independence.
The possibility for the general public to access guide-
lines is a fundamental requisite. In Italy, for example, 
the National Guidelines System (Sistema Nazionale 
Linee Guida) [6], which prepares recommendations for 
clinical behavior based on the most recent and updated 
scientific data, also elaborates versions for the public. 
The duty of guideline developers to make them avail-
able and easily accessible is absolute, especially when 
the issues addressed are of social and ethical impor-
tance. A classic example of this is the issue of “assisted 
suicide” in countries in which some form of euthanasia 
is allowed. One would expect total transparency in this, 
of all subjects, so that it is surprising to discover that it 
is not always present. 
It is as well to begin with a few preliminary consid-
erations:
- decisions regarding persons who are close to dying 
are of fundamental importance in bioethics. They di-
rectly involve the patients, their families, and health-
care workers. The ethical and regulatory framework sur-
rounding this topic has received considerable attention 
from legal, medical, and bioethical experts, as well as 
from those in numerous other fields. It is an issue to 
which no-one can remain indifferent, whatever their 
health status;
- the debate raging in various national parliaments fo-
ments a constant confrontation between the supporters 
and opponents of so-called “assisted suicide”, and there 
is an ample body of literature on the subject;
- the authors are convinced that assisted suicide is in-
compatible with medical ethics: the practice of medi-
cine is by its very nature aimed at the prevention, di-
agnosis, cure and treatment of disease: assisted suicide 
has no place in these aims. However, this is not the sub-
ject of the present article.
On 5th June 2014 the Assemblée Nationale du Qué-
bec adopted the “Loi concernant les soins de fin de vie” 
(Law concerning end-of-life care), which was passed on 
10th June 2014 [7]. 
On 10th September 2015 the Collège des Médecins 
du Québec (Quebec College of Physicians), the Ordre 
des Pharmaciens du Québec (Quebec Order of Phar-
macists), and the Ordre des Infirmières et Infirmiers 
du Québec (Quebec Order of Nurses) published the 
“Practice Guideline for medical aid in dying” (“Guide 
d’exercice sur l’aide médicale à mourir”) [8]. The guide 
“proposes regulations for the best possible medical aid 
in dying (MAD)” and has been applicable since De-
cember 2015, together with the law of 5th June 2014.
As noted above, it is not our intention here to add to 
the already ample literature on the subject of euthana-
sia. We would like instead to draw attention to a lack of 
transparency in the document published by the Collège 
des Médecins du Québec that has already been pointed 
out by the Physicians’ Alliance Against Euthanasia, ac-
cording to which in Article 7.2 of the Guide: “the Col-
lege orders doctors to falsify the real cause of death 
on the death certificate that is required by the Public 
Health Act, for patients who die by ‘medical aid in dy-
ing’ (MAD). This article clearly states that ‘the physi-
cian must write as an immediate cause of death the dis-
ease or morbid condition which justified the MAD. (…) 
The term ‘medical aid in dying’ should not be included 
in this report. Indeed, such information, if revealed to 
uninformed relatives, could firstly go against the will of 
a patient wishing to keep this information confidential 
and, secondly, cause them harm. This instruction by the 









College is contrary to Article 19 of the Public Health 
Act Regulation which stipulates that ‘the cause of death 
must be indicated in the most accurate manner pos-
sible’. It goes without saying that such a practice consti-
tutes a severe breach of ethics, and it will inevitably lead 
to serious abuse, in addition to distorting the official 
statistics on the real causes of death in Quebec” [9].
This accusation of violation of medical ethics led us to 
check the original document, which, since it addresses a 
crucial issue for patients, physicians and physician-pa-
tient relations, one would expect to be readily available 
to everyone. Instead, an internet search for the docu-
ment entitled “Guide d’Exercice sur l’Aide Médicale à 
Mourir” on the website of the Collège des Médecins 
du Québec surprisingly leads to a notice advising visi-
tors to the site that the document can be found on the 
College’s secure site, while “toutes les autres personnes 
qui souhaitent obtenir ce document doivent en faire la 
demande selon la procédure d’accès à l’information” (all 
other persons wishing to obtain the document should 
apply in accordance with ‘Access to Information’ pro-
cedures), for which an email address is supplied. We 
applied as instructed and with laudable promptness re-
ceived, after only a few hours, the pdf version of the 
document and a courteous accompanying letter from 
the College secretariat. The letter contained this cau-
tionary note: “Considérant que ce guide contient des 
informations cliniques sensibles, nous vous invitons à 
faire preuve de prudence dans la diffusion de ces infor-
mations et à diriger les gens qui souhaitent avoir un ex-
emplaire du document vers le Collège des Médecins du 
Québec” (As this guide contains sensitive clinical data, 
we would invite you to use prudence in circulating this 
information and to direct anyone wishing to obtain a 
copy of the document to the Collège des Médecins du 
Québec). In every nation the term “clinically sensitive 
data” is used to describe an individual’s physical or men-
tal health condition. In a non-clinical setting, “sensitive 
data” are those relating to racial or ethnic origin, po-
litical opinions, religious or other similar beliefs, mem-
bership of a trade union, sexual preferences, criminal 
convictions or proceedings [10]. The College Guide-
line, however, contains no “sensitive data”, only generic 
procedures. It is therefore difficult to understand why 
such a document which, because of the importance of 
its subject matter should be available to everybody and 
freely debated, is instead kept under wrappers. 
The Supreme Court’s ruling has been attacked as 
placing people “at risk with no procedural safeguards, 
no ongoing monitoring and unclear policies around 
access” [11]. This unclear policy around access seems 
a lack of transparency and an infringement of the Ca-
nadian “Guidelines 2.0: systematic development of 
a comprehensive checklist for a successful guideline 
enterprise” [12], which devote a whole step (n. 16) to 
“Dissemination and implementation” of guidelines.
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